1. Home
  2. TOVX vs BBW Comparison

TOVX vs BBW Comparison

Compare TOVX & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TOVX

Theriva Biologics Inc.

HOLD

Current Price

$0.22

Market Cap

7.3M

Sector

Health Care

ML Signal

HOLD

Logo Build-A-Bear Workshop Inc.

BBW

Build-A-Bear Workshop Inc.

HOLD

Current Price

$64.63

Market Cap

696.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
TOVX
BBW
Founded
2001
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Recreational Games/Products/Toys
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
7.3M
696.0M
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
TOVX
BBW
Price
$0.22
$64.63
Analyst Decision
Hold
Strong Buy
Analyst Count
1
7
Target Price
N/A
$67.71
AVG Volume (30 Days)
10.6M
404.4K
Earning Date
11-12-2025
12-04-2025
Dividend Yield
N/A
1.38%
EPS Growth
N/A
15.02
EPS
N/A
4.36
Revenue
N/A
$525,767,000.00
Revenue This Year
N/A
$8.05
Revenue Next Year
N/A
$4.31
P/E Ratio
N/A
$14.60
Revenue Growth
N/A
6.17
52 Week Low
$0.17
$32.55
52 Week High
$2.03
$75.85

Technical Indicators

Market Signals
Indicator
TOVX
BBW
Relative Strength Index (RSI) 49.78 70.42
Support Level $0.19 $58.69
Resistance Level $0.26 $66.17
Average True Range (ATR) 0.03 2.80
MACD 0.01 0.76
Stochastic Oscillator 60.57 88.86

Price Performance

Historical Comparison
TOVX
BBW

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

Share on Social Networks: